Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 06, 2016 07:00 ET | Source: Angiochem

Angiochem's ANG1005 Shows Clinical Benefit and Prolonged Survival in Phase II Trial

MONTREAL, QC--(Marketwired - June 06, 2016) - Angiochem, a biotechnology company developing peptide-drug conjugates uniquely capable of crossing the blood-brain barrier, presented data during a...
May 18, 2016 07:00 ET | Source: Angiochem

Angiochem to Present at ASCO 2016

MONTREAL, QC--(Marketwired - May 18, 2016) - Angiochem, a biotechnology company developing peptide-drug conjugates uniquely capable of crossing the blood-brain barrier, announced it will make an...
May 04, 2016 07:00 ET | Source: Angiochem

Angiochem Announces End-of-Phase 2 Meeting With FDA

MONTREAL, QC--(Marketwired - May 04, 2016) - Angiochem, a biotechnology company developing ANG1005 for the treatment of Leptomeningeal Carcinomatosis in patients with breast cancer and brain...
April 28, 2016 07:00 ET | Source: Angiochem

Angiochem Appoints Executive Chairman and Elects New Board of Directors

MONTREAL, QC--(Marketwired - April 28, 2016) - Angiochem, a biotechnology company developing peptide drug conjugates uniquely capable of crossing the blood-brain barrier, has appointed Mr. John...
February 15, 2011 07:00 ET | Source: Angiochem Inc.

La société américaine National Brain Tumor Society remet à Angiochem le prix de l'innovation pour souligner le développement de nouveaux traitements contre le cancer de cerveau

MONTRÉAL, CANADA et WATERTOWN, MASSACHUSETTS--(Marketwire - 15 fév. 2011) - Angiochem, inc., une entreprise de biotechnologie au stade clinique, et la National Brain Tumor...
February 15, 2011 07:00 ET | Source: Angiochem Inc.

Angiochem Receives Innovation Award From the National Brain Tumor Society for Advancing the Development of Novel Brain Cancer Treatments

MONTREAL, CANADA, and WATERTOWN, MASSACHUSETTS--(Marketwire - Feb. 15, 2011) - Angiochem, Inc., a clinical stage biotechnology company, and the National Brain Tumor Society (NBTS), a...